Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 80
  • Journal CiteScore: 29.12
  • Journal Impact Factor: 19.45*
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +44 7460731551

- (2009) Volume 10, Issue 3

Early ERCP in Acute Gallstone Pancreatitis without Cholangitis: A Meta-analysis

Manley C Uy, Ma Lourdes O Daez, Peter P Sy, Virgilio P Banez, Wendell Z Espinosa, Marilyn C Talingdan-Te

Section of Gastroenterology, Department of Medicine, Philippine General Hospital, University of the Philippines. Manila, Philippines

*Corresponding Author:
Manley C Uy
Gastrointestinal Clinic, 1st floor
Central Block, Philippine General Hospital,
Taft Avenue, Ermita 1000, Manila, Philippines
Phone: +63-2.567.2983
Fax: +63-2.567.2983
E-mail: sutzeran@yahoo.com

Received February 2nd, 2009 - Accepted March 5th, 2009

Visit for more related articles at Journal of the Pancreas

Abstract

Context Early ERCP was reported to result in recovery from acute gallstone pancreatitis. To date, several RCTs comparing it to conservative treatment have yielded different results. Objective We conducted a meta-analysis to determine the effect of early ERCP on the morbidity and mortality of acute gallstone pancreatitis without cholangitis. Methods We searched the following databases up to January 11th, 2008: the Cochrane Library, MEDLINE, EMBASE, the Australasian Medical Index, Latin American Caribbean Health Sciences Literature, and the Health Research and Development Information Network. References were scrutinized. Authors were contacted. There were no restrictions regarding language, publication date or publication status. Results Seven RCTs were retrieved, but only two RCTs involving 177 treated patients and 163 control patients were included. A meta-analysis on morbidity was inconclusive (RR=0.95, 95% CI: 0.74-1.22). Meta-analysis on mortality only showed a trend in favor of conservative management (RR=1.92, 95% CI: 0.86-4.32) for both mild and severe pancreatitis. Conclusions There is a trend towards more mortality from early ERCP with or without sphincterotomy in the setting of acute gallstone pancreatitis without cholangitis. However, more studies are needed. In the meantime, early ERCP should not be carried out unless there is at least a slight suspicion of cholangitis or persistent ampullary obstruction.

Keywords

Cholangiopancreatography, Endoscopic Retrograde; Gallstones; Pancreatitis

INTRODUCTION

Persistent ampullary obstruction by an impacted stone or by ampullary edema following stone passage may result in pancreatic edema, inflammation [1], hemorrhage and necrosis with a mortality rate of 13- 50% [2]. Accordingly, early relief of the obstruction is believed to halt the progression of severe attacks as well as prevent the evolution of mild attacks [1]. Early surgical removal of gallstones has been advocated [2]; however, a 1979 study by Ranson showed that surgery within one week of admission in severe pancreatitis was associated with a mortality rate of 67%. This was confirmed by the 1988 randomized controlled trial (RCT) of Kelly and Wagner on 165 patients which showed that surgery within 48 h of admission in severe pancreatitis was associated with a mortality rate of 47.8% as compared to 11.8% with delayed surgery [3]. This led to the abandonment of early surgery. The alternative, endoscopic retrograde cholangiopancreatography with or without endoscopic sphincterotomy, was demonstrated by Classen et al. in 1978 to result in the complete removal of bile duct stones and recovery from pancreatitis in 17 patients [4]

However, difficult cannulation and pancreatic contrast injection during ERCP may potentially worsen pancreatitis. So the question is: would ERCP with or without endoscopic sphincterotomy for biliary obstruction from retained stones or ampullary edema benefit patients with gallstone acute pancreatitis without cholangitis? The results of 7 RCTs comparing early ERCP with or without endoscopic sphincterotomy with conservative treatment yielded contradictory results [1, 2, 5, 6, 7, 8, 9]. We conducted a meta-analysis to determine the effect of early ERCP with or without endoscopic sphincterotomy on the morbidity and mortality of gallstone acute pancreatitis without cholangitis, the latter being an independent indication for early ERCP.

METHODS

Identification and Selection of Studies

Relevant studies were identified and selected by searching the following databases: the Cochrane Library, MEDLINE, EMBASE, the Australasian Medical Index (AMI), Latin American Caribbean Health Sciences Literature (LILACS), and the Health Research and Development Information Network (HERDIN) up to January 11th, 2008 using the search strategy "Gallstone" OR "Gallstone [MESH]" AND "Pancreatitis" OR "Pancreatitis [MESH]" AND "endoscopic retrograde cholangiopancreatography" OR "endoscopic retrograde cholangiopancreatography [MESH]" AND "randomized controlled trial" OR "randomized controlled trial [MESH]" AND "cholangitis" OR "cholangitis [MESH]" where applicable. We also did a full manual search from the reference lists of the trials selected. Authors of the trials retrieved were also contacted for information concerning any trials and relevant unpublished materials. There were no restrictions regarding language, publication date or publication status.

The following selection criteria were applied: 1) study population: gallstone acute pancreatitis patients without cholangitis; 2) intervention: early ERCP with or without endoscopic sphincterotomy vs. conservative treatment within at most 72 h of admission; 3) outcome measures: incidence of morbidity and mortality; 4) study design: randomized controlled trial to guarantee control of selection bias. Papers identified by the searches were evaluated and any papers unrelated to this review were excluded. Decisions at this stage were made based upon the title and abstract. Inclusion decisions were guided by eligibility criteria.

Data Extraction

The following relevant information was also extracted and recorded: country of origin, inclusion and exclusion criteria used, baseline comparability between treatment groups, comparison of types of treatment and number of patients in each arm, drop-outs reported and their reasons, incidence of mortality and morbidity, treatment carried out, and adverse events. In some studies, the reported overall incidence was not used as we had to account for those with baseline cholangitis. One study (Fölsch et al.) [6] did not report mortality and morbidity data according to the severity of baseline pancreatitis. Data reported by the meta-analysis of Ayub et al. [10] as provided by Fölsch et al. were used. Data were entered into Review Manager software (RevMan 4.2, Cochrane Collaboration, Oxford, England, United Kingdom; https://www.cc-ims.net/RevMan).

Quality of Methodology

The methodological quality of the studies included in the meta-analysis was scored using the Jadad composite scale. This is a 5-point quality scale, with low-quality studies having a score of less than 3 and high-quality studies having a score ≥ 3. Each study was given an overall quality score based on the above criteria, which was then used to rank the studies.

STATISTICS

The data analysis was carried out using the fixed-effect model with the meta-analysis Review Manager software (RevMan 4.2, Cochrane Collaboration, Oxford, England). The dichotomous mortality and morbidity data were expressed as relative risks (RR), together with 95% confidence intervals (95% CI). The relative risk of adverse events was used for 3 reasons: 1) there is empirical evidence that relative effect measures are, on the average, more consistent than absolute measures; 2) there is also empirical evidence that risk ratios of the adverse outcome are more consistent than ratios of the non-event and 3) it is a concept more familiar to patients and health professionals, and its interpretation is less complicated than for odds. We tested inconsistency between trials with the I2 statistic which describes the percentage of the variability in effect estimates which is due to heterogeneity rather than sampling error (chance), with a value greater than 50% considered as substantial heterogeneity. Funnel plots to address whether there exists publication bias could not be done due to the small number of studies.

RESULTS

Description of Selected Studies

The search strategy yielded 7 studies. Initially, 3 were included (Table 1) and 4 were excluded (Table 2). In general, the studies included involved patients with gallstone acute pancreatitis without cholangitis. Fölsch et al. [6] and Oría et al. [1] specifically excluded acute cholangitis, Neoptolemos et al. [7] provided the information according to the presence or absence of cholangitis.

table

table

The methodological quality scores of the 3 RCTs included ranged from 2-3 (Table 3): Neoptolemos et al. [7] got a 2 as they did not mention their method of randomization, Fölsch et al. [6] and Oría et al. [1] both got 3. None of them were double blinded. We decided to go ahead with the meta-analyses as ERCP is a complex invasive intervention not amenable to complete blinding. Follow-up and exclusion data are complete. There are no concerns regarding selective reporting.

table

Meta-Analyses of Clinical Events

Using a fixed effects model, an overall meta-analysis on the effect of early ERCP with or without endoscopic sphincterotomy on morbidity of acute pancreatitis was inconclusive (RR=0.82, 95% CI: 0.64-1.04). Morbidity meta-analyses for mild and severe pancreatitis were also inconclusive (Table 4).

table

As for mortality, an overall meta-analysis was also inconclusive (RR 1.22, 95% CI: 0.61-2.45). Separate meta-analyses according to the severity of the pancreatitis were also inconclusive for both mild and severe pancreatitis (Table 4).

Tests of heterogeneity using the I2 test revealed that the majority of the meta-analyses carried out were heterogeneous. This could be due to the various enrollment criteria of the studies included, i.e., the endoscopic community is hampered by a lack of a strict definition of biliary pancreatitis [3]. A review of these RCTs revealed that the study of Neoptolemos et al. [7] had a relatively lower methodological quality. Furthermore, this study recruited patients “n” hours after admission while the other two studies recruited patients “n” hours after symptom onset. As those who had onset of symptoms long before admission may already have had subsiding gallstone acute pancreatitis, the eventual benefit of ERCP with or without endoscopic sphincterotomy in the study of Neoptolemos et al. may be ascribed to relief of the biliary obstruction, not pancreatitis [1]. This could have biased the outcome in favor of ERCP with or without the endoscopic sphincterotomy group. Therefore, a sensitivity analysis with deselection of the study of Neoptolemos et al. was carried out. Not surprisingly, this yielded more homogenous meta-analyses and different results (Figures 1, 2, 3, 4, 5, 6). Although, overall morbidity meta-analyses were still inconclusive, an overall mortality meta-analysis appeared to be in favor of conservative management. The same applied for meta-analyses performed according to pancreatitis severity.

figure

figure

figure

figure

figure

DISCUSSION

There have been several meta-analyses on the subject. The 1999 meta-analysis of Sharma et al. [4] concluded that ERCP with or without endoscopic sphincterotomy reduces morbidity and mortality in gallstone acute pancreatitis. However, this meta-analysis included the studies of Fan et al. [2] and Nowak et al. [8]. The 2004 meta-analysis of Ayub et al. [10] for Cochrane and the recent 2008 meta-analysis of Moretti et al. [11] both concluded that early ERCP with or without endoscopic sphincterotomy may reduce the odds of having complications in predicted severe gallstone acute pancreatitis, but both also included the study of Fan et al. [2]. Moretti et al. [8] also included the studies of Neoptolemos et al. [7] and Zhou et al. [9]. Moreover just recently in 2008, Petrov et al. [12] reported a metaanalysis which concluded that early ERCP with or without endoscopic sphincterotomy did not reduce complications and mortality of gallstone acute pancreatitis. However, they also included the study of Neoptolemos et al. [7]. The result of this latter metaanalysis was similar to our initial meta-analysis (prior to sensitivity analysis).

The results of our present meta-analysis were different in that they not only suggested that early ERCP with or without endoscopic sphincterotomy might be unnecessary but also that it might possibly lead to higher mortality in both mild and severe gallstone acute pancreatitis. This was not in alignment with current guidelines on the management of gallstone acute pancreatitis which recommend early ERCP for severe gallstone acute pancreatitis [13, 14, 15, 16, 17]. Alhough this is only a trend (P>0.05), it is worth noting that a recent audit revealed that a low compliance of 48% with the UK guideline for 100% ERCP with or without endoscopic sphincterotomy for severe gallstone acute pancreatitis did not increase the complication or mortality rates from severe acute pancreatitis [18].

The following should be considered in the interpretation of the results of this meta-analysis. First, individual patient data were not used.

Second, the cumulative study population is relatively small at 340. The inconclusiveness of the metaanalyses may be due to type II error. Third, the studies included did not have a placebo group.

Fourth, only about half of the patients in the studies included (Fölsch et al. 46% [6], Oría et al. 66% [1]) who underwent a successful ERCP were found to have choledocholithiasis. Indeed, by not excluding patients without choledocholithiasis, these studies may have skewed the possibility of detecting the benefits of early ERCP with or without endoscopic sphincterotomy. Fan et al. [2] showed that, in the presence of confirmed biliary stones, the morbidity rates in the group undergoing early ERCP with or without endoscopic sphincterotomy were significantly lower than those in the conservative-treatment group (P=0.03). They also showed that the mortality rate was lower (P=0.09). The study of Acosta et al. [5] on patients with gallstone acute pancreatitis with ampullary obstruction showed that limiting the duration of the obstruction to not longer than 48 hours by ERCP with or without endoscopic sphincterotomy decreased morbidity. Unfortunately, they did not exclude those with mild cholangitis. In relation to this, the low proportion of patients with confirmed choledocholithiasis reflects the fact that the present definitions of gallstone acute pancreatitis aim to diagnose gallstone acute pancreatitis and not choledocholithiasis. In addition, gallstone acute pancreatitis as we all know, is more often associated with small stones which can transiently obstruct the common bile duct, cause pancreatitis or papillary edema, and pass into the duodenum. Therefore, we need a reliable way of detecting the presence of choledocholithiasis. A recent RCT comparing EUS with or without ERCP with endoscopic sphincterotomy (in the case of choledocholithiasis) to ERCP with or without endoscopic sphincterotomy in 140 patients with gallstone acute pancreatitis showed a more successful examination of the biliary tree with comparable morbidity and mortality risks in patients undergoing EUS with or without ERCP with endoscopic sphincterotomy. Thus, by identifying persistent ampullary obstruction, EUS may spare those who have already passed their stones from an unnecessary invasive procedure, thus preventing the potential risk of ERCP-associated complications [19]. This result was confirmed by Polkowski et al. [20] and Lee et al. [21]. These studies support the recommendations of the British Society of Gastroenterology guidelines that EUS or MR be used to confirm the presence of choledocholithiasis taking into account accessibility and local expertise. They perform better than ultrasound or CT scan [17].

Fifth, the two studies selected included different types of gallstone acute pancreatitis patients. Fölsch et al. [6] excluded all patients with obstructive jaundice while Oría et al. [1] excluded patients with cholangitis, but included those with obstructive jaundice. The fact that, in terms of mortality, the study of Fölsch et al. [6] has more of a trend in favor of the control group than does the study of Oría et al. [1] does could be due to the absence of the need for ERCP with or without endoscopic sphincterotomy in patients without obstructive jaundice.

Finally, it should be noted that gallstone acute pancreatitis by itself may also present with signs of cholangitis-like right upper quadrant pain, fever and jaundice [22]. Moreover, the diagnosis of cholangitis is often problematic because signs and symptoms pointing to the biliary tract as the source of sepsis are often absent in the critical early period of the disease. More importantly, of all the complications of gallstones, cholangitis kills the most swiftly [23].

Adequately powered randomized placebo-controlled multicenter studies using patients diagnosed with a standardized definition of gallstone acute pancreatitis plus confirmed choledocholithiasis but without obstructive jaundice and/or acute cholangitis presenting within a clearly defined period after onset of the disease should be carried out in the future in order to explore the effect of early ERCP or EUS on specific local and systemic complications of gallstone acute pancreatitis. Alternatively, a meta-analysis using individual patient data may provide an opportunity to analyze this. In the meantime, it might be prudent not to carry out early ERCP with or without endoscopic sphincterotomy in patients with gallstone acute pancreatitis unless there is at least a slight suspicion of cholangitis or persistent ampullary obstruction.

Potential conflict of interest

None known

References